Chief Physician, Professor, Doctoral Supervisor, Deputy Director of the Department of Genitourinary Oncology, Peking University Cancer Hospital; Member of the Bladder Cancer Quality Control Expert Committee of the National Cancer Quality Control Center; Board Member of the Chinese Society of Clinical Oncology (CSCO); Executive Board Member of the Youth Council of the Chinese Anti-Cancer Association; Standing Committee Member of the CSCO Urothelial Carcinoma Expert Committee; Standing Committee Member and Secretary-General of the CSCO Renal Cell Carcinoma Expert Committee; Standing Committee Member of the Chinese Anti-Cancer Association Genitourinary Oncology Committee; Deputy Leader of the Rare Subtype Renal Cell Carcinoma Collaboration Group of the Chinese Anti-Cancer Association Genitourinary Oncology Committee; Chair of the Youth Committee of the Beijing Anti-Cancer Association Genitourinary and Male Reproductive System Tumor Professional Committee; Chair-Elect of the Genitourinary Oncology Subcommittee of the Beijing Cancer Prevention and Treatment Research Association. Primarily engaged in multidisciplinary comprehensive treatment and translational research on genitourinary tumors such as renal cell carcinoma and bladder cancer, as well as malignant melanoma, with extensive clinical experience particularly in advanced renal cell carcinoma, urothelial carcinoma, and mucosal malignant melanoma. As the principal executor, completed multiple clinical studies on genitourinary tumors, especially advanced renal cell carcinoma, urothelial carcinoma, and melanoma, with related work recognized by domestic and international peers, and incorporated into the NCCN Guidelines for Renal Cell Carcinoma, the UK Guidelines for Head and Neck Mucosal Melanoma, and the CSCO Guidelines for the Diagnosis and Treatment of Renal Cell Carcinoma, Urothelial Carcinoma, and Melanoma. As a lead author, participated in the compilation of multiple editions of the CSCO Guidelines for Renal Cell Carcinoma, Urothelial Carcinoma, and Prostate Cancer, contributing to the standardized diagnosis and treatment of genitourinary tumors in China, and was recognized as an Outstanding Young Talent in Chinese Genitourinary Oncology. As the first or corresponding author, published multiple SCI articles in internationally renowned oncology journals such as the New England Journal of Medicine, JCO, JITC, and CCR, with a cumulative impact factor exceeding 200 points. As a key participant, received awards including the Second Prize of the Beijing Science and Technology Progress Award, the Second Prize of the Science and Technology Progress Award of the Chinese Anti-Cancer Association, the Third Prize of the Science and Technology Award of the Chinese Medical Association, and the Third Prize of the Huaxia Medical Award.